BACKGROUND: In developing countries, 8 to 71% of patients initiating highly active antiretroviral therapy (HAART) die within the first year of treatment. Apart from baseline CD4 count, viral load, hemoglobin, BMI and stage of the disease, there may be other variables that contribute to AIDS-related mortality. We investigated the potential role of nutrition, lipids and insulin resistance-related phenotypes in predicting early mortality. METHODS: We recruited 210 HAART-naïve HIV/AIDS patients in Lusaka, Zambia. Dietary intake, anthropometric measurements, fasting serum insulin, glucose, and lipid profiles were assessed at baseline. Mortality was assessed after 90 days of follow-up. We used logistic regression models to identify variables associated with mortality. RESULTS: The mean±SD for age, BMI and CD4 count at baseline were 34±7.4 y, 20±3 kg/m(2) and 138±52 cells/μL, respectively. Sixteen patients (7.6%) died during follow-up. Triglyceride concentrations were associated with increased mortality [odds ratio (OR) for 1 mmol/L increase in triglyceride concentration=2.51; 95% CI: 1.34-4.71]. This association remained significant (OR=3.24; 95% CI: 1.51-6.95) after adjusting for age, gender, smoking, alcohol use, total cholesterol, BMI, CD4 count and n3 fatty acid intake. Apart from higher n3 fat intake which was inversely associated with mortality (survivors: 1.81±0.99% total energy/day vs. non-survivors 1.28±0.66% energy/day, P=0.04), there were no other macronutrients associated with mortality. CONCLUSION: Triglyceride concentrations at the time of initiating HAART are independently associated with increased risk for early mortality. If this association is confirmed in larger studies, assessment of triglycerides could become part of routine care of HIV patients initiating HAART in developing countries.
BACKGROUND: In developing countries, 8 to 71% of patients initiating highly active antiretroviral therapy (HAART) die within the first year of treatment. Apart from baseline CD4 count, viral load, hemoglobin, BMI and stage of the disease, there may be other variables that contribute to AIDS-related mortality. We investigated the potential role of nutrition, lipids and insulin resistance-related phenotypes in predicting early mortality. METHODS: We recruited 210 HAART-naïve HIV/AIDSpatients in Lusaka, Zambia. Dietary intake, anthropometric measurements, fasting serum insulin, glucose, and lipid profiles were assessed at baseline. Mortality was assessed after 90 days of follow-up. We used logistic regression models to identify variables associated with mortality. RESULTS: The mean±SD for age, BMI and CD4 count at baseline were 34±7.4 y, 20±3 kg/m(2) and 138±52 cells/μL, respectively. Sixteen patients (7.6%) died during follow-up. Triglyceride concentrations were associated with increased mortality [odds ratio (OR) for 1 mmol/L increase in triglyceride concentration=2.51; 95% CI: 1.34-4.71]. This association remained significant (OR=3.24; 95% CI: 1.51-6.95) after adjusting for age, gender, smoking, alcohol use, total cholesterol, BMI, CD4 count and n3 fatty acid intake. Apart from higher n3 fat intake which was inversely associated with mortality (survivors: 1.81±0.99% total energy/day vs. non-survivors 1.28±0.66% energy/day, P=0.04), there were no other macronutrients associated with mortality. CONCLUSION:Triglyceride concentrations at the time of initiating HAART are independently associated with increased risk for early mortality. If this association is confirmed in larger studies, assessment of triglycerides could become part of routine care of HIVpatients initiating HAART in developing countries.
Authors: R Handema; H Terunuma; F Kasolo; H Kasai; M Sichone; G Mulundu; X Deng; K Ichiyama; S Mitarai; M Honda; N Yamamoto; M Ito Journal: AIDS Res Hum Retroviruses Date: 2001-05-20 Impact factor: 2.205
Authors: Beatriz Grinsztejn; Valdilea G Veloso; Ruth K Friedman; Ronaldo I Moreira; Paula M Luz; Dayse P Campos; José H Pilotto; Sandra W Cardoso; Jeanne C Keruly; Richard D Moore Journal: AIDS Date: 2009-10-23 Impact factor: 4.177
Authors: Maria Cristina Marazzi; Giuseppe Liotta; Paola Germano; Giovanni Guidotti; A Doro Altan; Susanna Ceffa; Massimo Magnano San Lio; Karin Nielsen-Saines; Leonardo Palombi Journal: AIDS Res Hum Retroviruses Date: 2008-04 Impact factor: 2.205
Authors: Dorothea M Wunder; Nick A Bersinger; Christoph A Fux; Nicolas J Mueller; Bernard Hirschel; Matthias Cavassini; Luigia Elzi; Patrick Schmid; Enos Bernasconi; Bruno Mueller; Hansjakob Furrer Journal: Antivir Ther Date: 2007
Authors: Asgeir Johannessen; Ezra Naman; Bernard J Ngowi; Leiv Sandvik; Mecky I Matee; Henry E Aglen; Svein G Gundersen; Johan N Bruun Journal: BMC Infect Dis Date: 2008-04-22 Impact factor: 3.090
Authors: Christopher K Nyirenda; Edmond K Kabagambe; John R Koethe; James N Kiage; Benjamin H Chi; Patrick Musonda; Meridith Blevins; Claire N Bosire; Michael Y Tsai; Douglas C Heimburger Journal: J Nutr Metab Date: 2015-05-26
Authors: John R Koethe; Meridith Blevins; Christopher K Nyirenda; Edmond K Kabagambe; Janelle M Chiasera; Bryan E Shepherd; Isaac Zulu; Douglas C Heimburger Journal: J Nutr Metab Date: 2013-04-16
Authors: James N Kiage; Douglas C Heimburger; Christopher K Nyirenda; Melissa F Wellons; Shashwatee Bagchi; Benjamin H Chi; John R Koethe; Donna K Arnett; Edmond K Kabagambe Journal: Lipids Health Dis Date: 2013-04-10 Impact factor: 3.876